Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
European Wax Center, Inc. Announces Participation in the BofA Securities 2024 Consumer & Retail Conference
-
Nuwellis, Inc. Announces Fourth Quarter and Full Year 2023 Financial Results
-
Akari Therapeutics and Peak Bio Announce Definitive Agreement to Merge as Equals Creating an Expanded Pipeline That Features a Novel Antibody Drug Conjugate (ADC) Toolkit
-
Lipella Pharmaceuticals Announces FDA Clearance of IND for LP-410 for Oral Graft-Versus-Host Disease, Advancing Clinical Pipeline
-
Keros Therapeutics to Present at Leerink Partners 2024 Global Biopharma Conference
-
Avadel Pharmaceuticals to Present at Upcoming Investor Conferences
-
Inspire Medical Systems, Inc. to Present at the KeyBanc Life Sciences & MedTech Investor Forum
-
Replimune to Present at Three Upcoming Investor Conferences
-
Mainz Biomed Partners with Trusted Health Advisors to Support U.S. Go-To-Market Strategy for Next Generation Early Colorectal Cancer Diagnostic
-
Dorian Bailey Joins Locus Technologies to Lead Alliances and Customer Success
-
Allyx Therapeutics Announces Expansion into Parkinson’s Disease Clinical Research with Lead Compound ALX-001 Following IND Acceptance
-
Cogniteam Selects RTI Connext® to Enable Seamless Communication within its Cloud Robotics Platform
-
Snail Games Announces ARK Franchise Tops Charts at Steam's Dinos vs. Robots Fest
-
SensaSure Technologies and Verde Bio Holdings File Registration Statement for Previously Announced Merger
-
Tonix Pharmaceuticals Announces Translation of Preclinical Pharmacokinetic Parameters of TNX-1500 (Fc-modified humanized anti-CD40L mAb) Supports Monthly i.v. Dosing in Humans
-
Asure Software to Attend 36th Annual Roth Conference March 17-19th, 2024
-
La Rosa Announces Official Launch of Final Offer, a Transparent Negotiation Platform, in Two States
-
Navitas Semiconductor to Participate in Upcoming Investor Conferences
-
3D Systems Announces Additional Partial Repurchase of Convertible Senior Notes
-
Yoshitsu Co., Ltd.’s Subsidiary REIWATAKIYA LV LLC Enters into a Lease Agreement with Fashion Show Mall LLC to Expand Market Presence in the U.S. Market
-
Aemetis Receives Authority to Construct Air Permits for Riverbank Sustainable Aviation Fuel Plant
-
New HireVue Survey Unveils Shift: Forward-Thinking Hiring Leaders Prioritize Potential Over Past Experience
-
Akari Therapeutics and Peak Bio Announce Definitive Agreement to Merge as Equals Creating an Expanded Pipeline That Features a Novel Antibody Drug Conjugate (ADC) Toolkit
-
Perspective Therapeutics Acquires CGMP-Compliant Manufacturing Facility
-
Agrify Corporation Announces CEO Participation in Closing of Public Offering
-
RevoluGROUP Canada Inc. Provides Update on Discussions with Erik Riveros
-
Immutep Announces First Clinical Data from 90mg Dosing of Efti
-
Joni and Friends breaks ground on Joni’s House in Serbia
-
Liberty Star Begins Field Operations at Red Rock Canyon Gold Property, SE Arizona
-
Review Control (OTC:IMTL) Announces Enhanced API Capabilities Specifically Designed for Unprecedented Impact on the Restaurant and Food Service Sector
-
Snail Games Announces ARK Franchise Tops Charts at Steam's Dinos vs. Robots Fest
-
Compass Diversified Announces Appointment of Joshua Gaynor as President of Lugano Diamonds
-
Village Super Market, Inc. Reports Results for the Second Quarter Ended January 27, 2024
-
Eyenovia Congratulates Formosa Pharmaceuticals on FDA Approval of Clobetasol Propionate Ophthalmic Suspension 0.05% for the Treatment of Post-operative Inflammation and Pain Following Ocular Surgery
-
European Wax Center, Inc. Announces Participation in the BofA Securities 2024 Consumer & Retail Conference
-
Axonius Announces $200 Million Series E Extension Amid Explosive Growth
-
PetVivo Holdings, Inc. Commences Trading on Upstream Under PETV
-
authID to Report Fiscal Year 2023 Financial Results on March 20, 2024
-
HBO and Deep Focus Celebrate the Silver Anniversary of The Greatest Series of All Time
-
Gentex Announces First Quarter 2024 Cash Dividend
-
CervoMed Announces Presentation of Biomarker Data from the AscenD-LB Phase 2a Trial and Preclinical Data Supporting Potential of Neflamapimod in Tau-Mediated Disease at AD/PD ™ 2024
-
Gain Therapeutics Presents Data at the AD/PD™ 2024 Conference Demonstrating the Mechanism of Action of GT-02287, its Clinical Stage GCase Regulator for the Treatment of Parkinson’s Disease
-
Industry Veteran Tim Bertrand Joins HAProxy Technologies as President
-
INmune Bio Reports Significant EEG Improvement in Alzheimer’s Patients Treated with XPro™
-
NeoGames launches content with Georgia Lottery, expanding NeoGames Studio’s presence in US
-
Fulcrum Therapeutics to Participate at the Leerink Partners Global Biopharma Conference
-
Kalmar and APM Terminals join forces for straddle carrier electrification pilot at Pier 400 terminal in Los Angeles
-
Snack’in For You Debuts Better-for-You Veggie Puffs at Expo West
-
Purple Biotech Reports Fourth Quarter and Full-Year 2023 Financial Results
-
Lophos Pharmaceuticals Partners With Carmichael Engineering Ltd. for HVAC Project, Anticipates Expedited Building Occupancy
